Difference between revisions of "Craniotomy for extracranial-intracranial revascularization"
Chris Rishel (talk | contribs) m (Text replacement - "Art line" to "Arterial line") |
|||
(22 intermediate revisions by 3 users not shown) | |||
Line 2: | Line 2: | ||
| anesthesia_type = General | | anesthesia_type = General | ||
| airway = ETT | | airway = ETT | ||
| lines_access = PIV | | lines_access = PIV x2 | ||
| monitors = Standard ASA | Arterial line | ||
| monitors = Standard ASA | |||
5-lead EKG | 5-lead EKG | ||
| considerations_preoperative = | Core temp | ||
| considerations_intraoperative = | UOP | ||
| considerations_postoperative = | ABG | ||
EEG | |||
}} | | considerations_preoperative = Characterize neurologic deficits | ||
== Preoperative management == | Consider anxiolytic | ||
=== Patient evaluation === | | considerations_intraoperative = Smooth induction | ||
Maintain CPP | |||
Maximize flow to ischemic areas | |||
Decrease CMRO2 | |||
Smooth extubation | |||
| considerations_postoperative = Careful control of BP | |||
PONV prophylaxis | |||
}}'''Craniotomy for extracranial-intracranial revascularization''' (also referred to as '''EC-IC bypass''') is an intracranial procedure which augments cerebral blood flow by relocating an extracranial vessel intracranially. | |||
==Overview== | |||
===Indications=== | |||
An EC-IC bypass is performed when there is severe stenosis or occlusion of an intracranial artery. Some common scenarios include: | |||
* Moya-moya disease | |||
* Intracranial aneurysms which cannot be directly treated and require complete occlusion of the proximal artery | |||
===Surgical procedure=== | |||
The procedure is performed through a craniotomy. The extracranial source is most commonly the superficial temporal artery, but other branches of the external carotid artery are possible. The temporalis muscle or omentum can also be used when using an external carotid branch is not preferred.<ref>{{Cite book|url=https://www.worldcat.org/oclc/1117874404|title=Anesthesiologist's manual of surgical procedures|date=2020|others=Richard A. Jaffe, Clifford A. Schmiesing, Brenda Golianu|isbn=978-1-4698-2916-6|edition=6|location=Philadelphia|oclc=1117874404}}</ref> | |||
The extracranial source is then routed through the craniotomy, and revascularization is achieved in one of two approaches: | |||
* "Direct", where the extracranial vessel is directly anastomosed to an intracranial vessel (typically to a branch of the middle cerebral artery) | |||
* "Indirect", where the donor source is laid on the surface of the brain but not directly anastomosed, with the expectation that over time vascular growth will occur to provide additional flow to the brain. | |||
==Preoperative management== | |||
===Patient evaluation=== | |||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||
Line 17: | Line 43: | ||
!Considerations | !Considerations | ||
|- | |- | ||
|Neurologic | | Neurologic | ||
| | | | ||
*Patients typically present with variable focal neurologic symptoms, which should be well characterized and documented | |||
|- | |- | ||
|Cardiovascular | |Cardiovascular | ||
| | | | ||
*Hypertension is a common adaptive response to maintain CPP | |||
**Normotension may be undesirable in the setting of severe cerebrovascular disease | |||
**Patients are often treated with midodrine preoperatively to induce hypertension and improve CPP | |||
|- | |- | ||
|Hematologic | |Hematologic | ||
| | | | ||
*Patients often on aspirin through day of surgery | |||
*Anticoagulants impacting PT/PTT typically discontinued 1 week prior to surgery | |||
|} | |} | ||
=== Labs and studies === | ===Labs and studies=== | ||
=== Operating room setup === | |||
=== Patient preparation and premedication === | *EKG | ||
=== Regional and neuraxial techniques <!-- Describe any potential regional and/or neuraxial techniques which may be used for this case. If none, this section may be removed. --> === | *Echo (if concern for cardiovascular disease) | ||
*Coronary angiography (depending on cardiac risk factors) | |||
*Complete blood count | |||
*Chemistry panel | |||
*Coagulation panel | |||
*Cerebral angiography performed to identify cause of neurologic symptoms | |||
===Operating room setup=== | |||
*Infusion pumps | |||
*If inducing hypothermia | |||
**Surface cooling device (i.e. cold-water circulating blanket) | |||
**Warming device | |||
***Patient will need aggressive rewarming post-anastomosis | |||
***Consider bladder irrigation, warm-water circulating blanket, forced warm air blanket | |||
** Consider central heat exchanger, especially if patient has high surface-to-volume ratio | |||
===Patient preparation and premedication === | |||
*Consider aprepitant if patient has history of severe PONV | |||
*Avoid scopolamine for PONV, as it may confound post-op neurologic exams | |||
*Anxiolysis typically reasonable | |||
===Regional and neuraxial techniques<!-- Describe any potential regional and/or neuraxial techniques which may be used for this case. If none, this section may be removed. -->=== | |||
*Avoid scalp blocks, as they may interfere with donor vessel blood flow | |||
=== | == Intraoperative management== | ||
===Monitoring and access<!-- List and/or describe monitors and access typically needed for this case. Please describe rationale for any special monitors or access. -->=== | |||
*Standard ASA monitors | |||
*5-Lead EKG | |||
*Core temperature | |||
*Urine output | |||
*Arterial blood pressure | |||
*EEG (particularly if inducing burst suppression) | |||
*Central line typically not required | |||
=== | ===Induction and airway management<!-- Describe the important considerations and general approach to the induction of anesthesia and how the airway is typically managed for this case. -->=== | ||
=== | *Maintain controlled hypertension throughout induction (MAPs 90-110) to maintain cerebral perfusion pressure | ||
**One effective approach is to use high-dose narcotic (fentanyl 7-10 mcg/kg) and low-dose propofol (0.5 mg/kg) | |||
***Limits postinduction hypotension | |||
***Prevents hemodynamic response to laryngoscopy | |||
**Ephedrine may preserve cerebral blood flow better than phenylephrine<ref name=":0">{{Cite journal|last=Koch|first=Klaus U.|last2=Mikkelsen|first2=Irene K.|last3=Aanerud|first3=Joel|last4=Espelund|first4=Ulrick S.|last5=Tietze|first5=Anna|last6=Oettingen|first6=Gorm V.|last7=Juul|first7=Niels|last8=Nikolajsen|first8=Lone|last9=Østergaard|first9=Leif|last10=Rasmussen|first10=Mads|date=2020|title=Ephedrine versus Phenylephrine Effect on Cerebral Blood Flow and Oxygen Consumption in Anesthetized Brain Tumor Patients: A Randomized Clinical Trial|url=https://pubmed.ncbi.nlm.nih.gov/32482999|journal=Anesthesiology|volume=133|issue=2|pages=304–317|doi=10.1097/ALN.0000000000003377|issn=1528-1175|pmid=32482999}}</ref> | |||
* Muscle relaxant may require reversal if neuromonitoring is used | |||
== | ===Positioning<!-- Describe any unique positioning considerations, including potential intraoperative position changes. If none, this section may be removed. -->=== | ||
*Supine | |||
*Table turned 180 | |||
*Mayfield skull fixation | |||
**Prior to pinning, a remifentanil bolus (2-4mcg/kg) is useful to minimize hemodynamic lability | |||
*Shoulder roll | |||
=== | ===Maintenance and surgical considerations<!-- Describe the important considerations and general approach to the maintenance of anesthesia, including potential complications. Be sure to include any steps to the surgical procedure that have anesthetic implications. -->=== | ||
= | *Anesthesia is typically maintained with a combination of a general anesthetic and remifentanil | ||
*Controlled hypertension (MAPs 90-110) to preserve cerebral perfusion pressure | |||
**Ephedrine boluses may be preferable to improve cerebral blood flow<ref name=":0" /> and avoid reflexive bradycardia | |||
**Phenylephrine infusion typically used to maintain CPP during procedure | |||
* Normocarbia | |||
**Cerebral vasoconstriction from hypocarbia may lead to cerebral ischemia in these patients | |||
*Normovolemia | |||
*Dexamethasone useful to reduce intracranial swelling and decrease PONV | |||
*Some centers use mild hypothermia (33-34°C) to decrease cerebral metabolic rate and increase tolerance to ischemia | |||
*Preincision antibiotics | |||
*If performing a direct anastomosis | |||
**Some centers use mild hypothermia (33-34 °C) for cerebral protection | |||
**Establish burst suppression (propofol 1mg/kg) immediately prior to cross clamping of cerebral artery | |||
***Theoretical benefit of decreasing cerebral metabolic rate and increasing tolerance for ischemia, though evidence is limited | |||
***A bolus dose of ephedrine and/or phenylephrine typically needed to counterbalance hypotensive effect of propofol | |||
===Emergence<!-- List and/or describe any important considerations related to the emergence from anesthesia for this case. -->=== | |||
{| class="wikitable" | *Controlled hypertension typically maintained in postoperative period even if direct anastomosis performed | ||
**Titrate vasoactive infusions down as anesthetic weaned | |||
**If excessive hypertension develop, beta-blockers (esmolol, labetalol) and/or vasodilators (clevidipine, SNP) may be needed to maintain control during emergence | |||
*Long-acting opioids typically not needed and may interfere with postoperative neurologic examination | |||
*Consider IV acetaminophen | |||
*Consider emergence and extubation on low-dose remifentanil (0.05 mcg/kg/min) to minimize bucking and hemodynamic lability | |||
== Postoperative management== | |||
===Disposition<!-- List and/or describe the postoperative disposition and any special considerations for transport of patients for this case. -->=== | |||
*ICU (typically monitored overnight in ICU) | |||
*Supplemental O2 | |||
*Head of bed at 20-30° | |||
*Tight BP monitoring and management post-op (typically maintain at baseline levels) | |||
*Regular neuro checks post-op | |||
===Pain management<!-- Describe the expected level of postoperative pain and approaches to pain management for this case. -->=== | |||
*Multimodal pain management | |||
*Consider acetaminophen | |||
*Avoid scalp blocks, as they can interfere with donor vessel blood flow | |||
===Potential complications<!-- List and/or describe any potential postoperative complications for this case. -->=== | |||
*Seizures | |||
*Stroke | |||
*Hemorrhage at anastomosis | |||
*Brain swelling can be caused by hyperemia in revascularized areas | |||
==Procedure variants== | |||
{| class="wikitable wikitable-horizontal-scroll" | |||
|+ | |+ | ||
! | ! | ||
! | !"Direct" revascularization | ||
! | !"Indirect" revascularization | ||
|- | |- | ||
|Unique considerations | |Unique considerations | ||
| | |Involves temporary clipping of intracranial vessel to perform anastomosis | ||
Cerebral protection strategies may include burst suppression and mild hypothermia | |||
| | | | ||
|- | |- | ||
|Surgical time | |Surgical time | ||
| | |↑ | ||
| | |↓ | ||
|- | |- | ||
|Potential complications | |Potential complications | ||
| | |Cerebral infarction | ||
| | | | ||
|} | |} | ||
== References == | ==References== | ||
<references /> | <references /> | ||
[[Category:Surgical | [[Category:Surgical procedures]] | ||
[[Category:Neurosurgery]] | |||
[[Category:Intracranial neurosurgery]] |
Latest revision as of 11:40, 5 April 2022
Anesthesia type |
General |
---|---|
Airway |
ETT |
Lines and access |
PIV x2 Arterial line |
Monitors |
Standard ASA 5-lead EKG Core temp UOP ABG EEG |
Primary anesthetic considerations | |
Preoperative |
Characterize neurologic deficits Consider anxiolytic |
Intraoperative |
Smooth induction Maintain CPP Maximize flow to ischemic areas Decrease CMRO2 Smooth extubation |
Postoperative |
Careful control of BP PONV prophylaxis |
Article quality | |
Editor rating | |
User likes | 2 |
Craniotomy for extracranial-intracranial revascularization (also referred to as EC-IC bypass) is an intracranial procedure which augments cerebral blood flow by relocating an extracranial vessel intracranially.
Overview
Indications
An EC-IC bypass is performed when there is severe stenosis or occlusion of an intracranial artery. Some common scenarios include:
- Moya-moya disease
- Intracranial aneurysms which cannot be directly treated and require complete occlusion of the proximal artery
Surgical procedure
The procedure is performed through a craniotomy. The extracranial source is most commonly the superficial temporal artery, but other branches of the external carotid artery are possible. The temporalis muscle or omentum can also be used when using an external carotid branch is not preferred.[1]
The extracranial source is then routed through the craniotomy, and revascularization is achieved in one of two approaches:
- "Direct", where the extracranial vessel is directly anastomosed to an intracranial vessel (typically to a branch of the middle cerebral artery)
- "Indirect", where the donor source is laid on the surface of the brain but not directly anastomosed, with the expectation that over time vascular growth will occur to provide additional flow to the brain.
Preoperative management
Patient evaluation
System | Considerations |
---|---|
Neurologic |
|
Cardiovascular |
|
Hematologic |
|
Labs and studies
- EKG
- Echo (if concern for cardiovascular disease)
- Coronary angiography (depending on cardiac risk factors)
- Complete blood count
- Chemistry panel
- Coagulation panel
- Cerebral angiography performed to identify cause of neurologic symptoms
Operating room setup
- Infusion pumps
- If inducing hypothermia
- Surface cooling device (i.e. cold-water circulating blanket)
- Warming device
- Patient will need aggressive rewarming post-anastomosis
- Consider bladder irrigation, warm-water circulating blanket, forced warm air blanket
- Consider central heat exchanger, especially if patient has high surface-to-volume ratio
Patient preparation and premedication
- Consider aprepitant if patient has history of severe PONV
- Avoid scopolamine for PONV, as it may confound post-op neurologic exams
- Anxiolysis typically reasonable
Regional and neuraxial techniques
- Avoid scalp blocks, as they may interfere with donor vessel blood flow
Intraoperative management
Monitoring and access
- Standard ASA monitors
- 5-Lead EKG
- Core temperature
- Urine output
- Arterial blood pressure
- EEG (particularly if inducing burst suppression)
- Central line typically not required
Induction and airway management
- Maintain controlled hypertension throughout induction (MAPs 90-110) to maintain cerebral perfusion pressure
- One effective approach is to use high-dose narcotic (fentanyl 7-10 mcg/kg) and low-dose propofol (0.5 mg/kg)
- Limits postinduction hypotension
- Prevents hemodynamic response to laryngoscopy
- Ephedrine may preserve cerebral blood flow better than phenylephrine[2]
- One effective approach is to use high-dose narcotic (fentanyl 7-10 mcg/kg) and low-dose propofol (0.5 mg/kg)
- Muscle relaxant may require reversal if neuromonitoring is used
Positioning
- Supine
- Table turned 180
- Mayfield skull fixation
- Prior to pinning, a remifentanil bolus (2-4mcg/kg) is useful to minimize hemodynamic lability
- Shoulder roll
Maintenance and surgical considerations
- Anesthesia is typically maintained with a combination of a general anesthetic and remifentanil
- Controlled hypertension (MAPs 90-110) to preserve cerebral perfusion pressure
- Ephedrine boluses may be preferable to improve cerebral blood flow[2] and avoid reflexive bradycardia
- Phenylephrine infusion typically used to maintain CPP during procedure
- Normocarbia
- Cerebral vasoconstriction from hypocarbia may lead to cerebral ischemia in these patients
- Normovolemia
- Dexamethasone useful to reduce intracranial swelling and decrease PONV
- Some centers use mild hypothermia (33-34°C) to decrease cerebral metabolic rate and increase tolerance to ischemia
- Preincision antibiotics
- If performing a direct anastomosis
- Some centers use mild hypothermia (33-34 °C) for cerebral protection
- Establish burst suppression (propofol 1mg/kg) immediately prior to cross clamping of cerebral artery
- Theoretical benefit of decreasing cerebral metabolic rate and increasing tolerance for ischemia, though evidence is limited
- A bolus dose of ephedrine and/or phenylephrine typically needed to counterbalance hypotensive effect of propofol
Emergence
- Controlled hypertension typically maintained in postoperative period even if direct anastomosis performed
- Titrate vasoactive infusions down as anesthetic weaned
- If excessive hypertension develop, beta-blockers (esmolol, labetalol) and/or vasodilators (clevidipine, SNP) may be needed to maintain control during emergence
- Long-acting opioids typically not needed and may interfere with postoperative neurologic examination
- Consider IV acetaminophen
- Consider emergence and extubation on low-dose remifentanil (0.05 mcg/kg/min) to minimize bucking and hemodynamic lability
Postoperative management
Disposition
- ICU (typically monitored overnight in ICU)
- Supplemental O2
- Head of bed at 20-30°
- Tight BP monitoring and management post-op (typically maintain at baseline levels)
- Regular neuro checks post-op
Pain management
- Multimodal pain management
- Consider acetaminophen
- Avoid scalp blocks, as they can interfere with donor vessel blood flow
Potential complications
- Seizures
- Stroke
- Hemorrhage at anastomosis
- Brain swelling can be caused by hyperemia in revascularized areas
Procedure variants
"Direct" revascularization | "Indirect" revascularization | |
---|---|---|
Unique considerations | Involves temporary clipping of intracranial vessel to perform anastomosis
Cerebral protection strategies may include burst suppression and mild hypothermia |
|
Surgical time | ↑ | ↓ |
Potential complications | Cerebral infarction |
References
- ↑ Anesthesiologist's manual of surgical procedures. Richard A. Jaffe, Clifford A. Schmiesing, Brenda Golianu (6 ed.). Philadelphia. 2020. ISBN 978-1-4698-2916-6. OCLC 1117874404.CS1 maint: others (link)
- ↑ 2.0 2.1 Koch, Klaus U.; Mikkelsen, Irene K.; Aanerud, Joel; Espelund, Ulrick S.; Tietze, Anna; Oettingen, Gorm V.; Juul, Niels; Nikolajsen, Lone; Østergaard, Leif; Rasmussen, Mads (2020). "Ephedrine versus Phenylephrine Effect on Cerebral Blood Flow and Oxygen Consumption in Anesthetized Brain Tumor Patients: A Randomized Clinical Trial". Anesthesiology. 133 (2): 304–317. doi:10.1097/ALN.0000000000003377. ISSN 1528-1175. PMID 32482999.
Top contributors: Chris Rishel and Barrett Larson